Drug interactions in antiarrhythmic therapy.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D004347:Drug Interactions; D004573:Electrolytes / Q000378:metabolism; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007668:Kidney / Q000187:drug effects / Q000378:metabolism; D007700:Kinetics; D008102:Liver Circulation / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D011485:Protein Binding / Q000187:drug effects; D011950:Receptors, Cholinergic / Q000187:drug effects; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000187:drug effects; D014018:Tissue Distribution / Q000187:drug effects
D000889:Anti-Arrhythmia Agents; D002395:Catecholamines; D004573:Electrolytes; D011950:Receptors, Cholinergic; D000254:Sodium-Potassium-Exchanging ATPase; D009638:Norepinephrine